Abstracts

Citation

Christen E Salyer, Thor A Wagner, Hannah C Huang, Kelly Richardson, Adriana Weinberg, Sharon Nachman, Lisa M Frenkel. H1N1 Influenza Vaccination does not appear to alter HIV-1 DNA Reservoirs. Presented at: PAS 2015 Annual Meeting.

Citation

S. Nachman, E. Andersen-Nissen, A. Gartland, J. Hural, M.J. McElrath, Z. Shi, J. Ishmukhamedov, A Coletti, Diaz Granados C , C. Worrell, P Jean-Philippe, M. Cotton, L. Fairlie, A. Violari, the P1113 study team. Interim safety and immunogenicity results IMPAACT P1113: Phase I/II Study of AERAS-404 In BCG-Primed Infants. Presented at: TB Vaccines Fourth global Forum.

Citation

MG Fowler, M Qin, S Fiscus, JS Currier, B Makanani, FE Martinson, T Chipato, R Browning, D Shapiro, LM Mofenson. Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission. Presented at: CROI 2015; 2015 Feb 24.

Citation

Cindy Vavro, Paul Palumbo, Andrew Wiznia, Carmelita Alvero, Bobbie Graham, Terry Fenton, Rohan Hazra, Ellen O’Gara, Ann M Buchanan, Joe Horton, Rolando M Viani. Evolution of HIV-1 Integrase Following Selection of R263K with Further Dolutegravir Treatment; A Case Report from the P1093 study. Presented at: IAS 2015.

Citation

Julie A E Nelson, Ali Fokar, Michael G Hudgens, Kara J Comliment, Gerald Tegha, Deborah Kamwendo, Athena P Kourtis, Denise J Jamieson, Charles Van Der Horst, Susan A Fiscus. NVP Resistance in Infants Infected by HIV-1 via Breastfeeding in the BAN Study. Presented at: CROI 2015; 2015 Feb 25.

Citation

Diana F Clarke, Jos Lommerse, Edward P Acosta, Edmund Capparelli, Anne Chain, Han Witjes , Hedy Teppler, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen A Spector, Betsy Smith, Mark Mirochnick. Modeling and simulation to facilitate development of neonatal raltegravir ARV dosing regimen: IMPAACT P1110. Presented at: Pediatric HIV Workshop 2015.

Citation

Michael Boivin, Miriam Chernoff, Jane Lindsey, Bonnie Zimmer, Barbara Laughton, Celeste Joyce, Katie McCarthy, Pim Brouwers, Patrick Jean-Philippe, Sonia Lee, Joan Coetzee, Avy Violari, Mark Cotton, Paul Palumbo. Initial findings from IMPAACT P1104s: a neuropsychological evaluation of HIV-infected and uninfected children in sub-Saharan Africa. Presented at: 7th International Workshop on HIV Pediatrics 2015.

Citation

Jos Lommerse, Diana Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edmund Capparelli, Edward Acosta, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen Spector, Betsy Smith, Mark Mairochnick. Raltegravir dosing in neonates (IMPAACT P1110) – Use of allometry and PK modeling to develop daily dosing strategy for investigation during first weeks of life. Presented at: Population Approach Group in Europe (PAGE) Meeting.

Citation

Michael Boivin, Miriam Chernoff, Jane Lindsey, Bonnie Zimmer, Barbara Laughton, Celeste Joyce, Katie McCarthy, Pim Brouwers, Patrick Jean-Philippe, Sonia Lee, Joan Coetzee, Avy Violari, Mark Cotton, Paul Palumbo. Initial findings from a neuropsychological evaluation of HIV-infected children from the IMPAACT P1104s Africa multi-site study, compared to HIV-uninfected controls at those sites. Presented at: IAS 2015.

Citation

Coleen Cunningham, Ulla Buchholz, Petronella Muresan, Elizabeth McFarland, Cindy Luongo, Peter Collins, Bhavin Thumar, Betty Schappell, Devasena Gnanashanmugam, George Siberry, Vivian Rexroad, Ruth Karron. Safety and immunogenicity of the recombinant live-attenuated respiratory syncytial virus vaccine RSV cps2 in RSV-seronegative infants and children. Presented at: ID Week 2015.